We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
25 hedge funds and large institutions have $15M invested in Regulus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 1
120% more capital invested
Capital invested by funds: $6.8M → $15M (+$8.15M)
4.46% more ownership
Funds ownership: 47.77% → 52.23% (+4.5%)
4% less funds holding
Funds holding: 26 → 25 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
12
Reduced
1
Closed
2
Calls
$580K
Puts
–
Net Calls
+$580K
Net Calls Change
+$251K
Top Buyers
Top Sellers
| 1 |
Jane Street
New York
|
-$15.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.33K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$655 |